- Home
- FLNT vs SCLX Comparison
FLNT vs SCLX Comparison
Compare FLNT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- SCLX
- Stock Information
- Founded
- FLNT 2001
- SCLX 2011
- Country
- FLNT United States
- SCLX United States
- Employees
- FLNT N/A
- SCLX N/A
- Industry
- FLNT Advertising
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- FLNT Consumer Discretionary
- SCLX Health Care
- Exchange
- FLNT Nasdaq
- SCLX Nasdaq
- Market Cap
- FLNT 39.2M
- SCLX 33.9M
- IPO Year
- FLNT N/A
- SCLX N/A
- Fundamental
- Price
- FLNT $1.87
- SCLX $4.73
- Analyst Decision
- FLNT Hold
- SCLX Strong Buy
- Analyst Count
- FLNT 1
- SCLX 3
- Target Price
- FLNT $3.00
- SCLX $367.50
- AVG Volume (30 Days)
- FLNT 21.6K
- SCLX 135.7K
- Earning Date
- FLNT 08-18-2025
- SCLX 08-12-2025
- Dividend Yield
- FLNT N/A
- SCLX N/A
- EPS Growth
- FLNT N/A
- SCLX N/A
- EPS
- FLNT N/A
- SCLX N/A
- Revenue
- FLNT $243,850,000.00
- SCLX $50,710,000.00
- Revenue This Year
- FLNT N/A
- SCLX $107.00
- Revenue Next Year
- FLNT $11.62
- SCLX $82.52
- P/E Ratio
- FLNT N/A
- SCLX N/A
- Revenue Growth
- FLNT N/A
- SCLX 7.79
- 52 Week Low
- FLNT $1.50
- SCLX $3.60
- 52 Week High
- FLNT $3.83
- SCLX $78.05
- Technical
- Relative Strength Index (RSI)
- FLNT 45.96
- SCLX 42.52
- Support Level
- FLNT $1.78
- SCLX $4.56
- Resistance Level
- FLNT $1.90
- SCLX $4.90
- Average True Range (ATR)
- FLNT 0.09
- SCLX 0.58
- MACD
- FLNT 0.02
- SCLX -0.10
- Stochastic Oscillator
- FLNT 51.85
- SCLX 4.73
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.